Joint estimation of CD4(+) cell progression and survival in untreated individuals with HIV-1 infection

摘要

Objective: We compiled the largest dataset of seroconverter cohorts to date from 25 countries across Africa, North America, Europe, and Southeast/East (SE/E) Asia to simultaneously estimate transition rates between CD4(+) cell stages and death, in antiretroviral therapy (ART)-naive HIV-1-infected individuals.